ISSN: 0959-4973
Journal Home
Journal Guideline
Anti-Cancer Drugs Q3 Unclaimed
Anti-Cancer Drugs is a journal indexed in SJR in Pharmacology and Oncology with an H index of 102. It has a price of 2040 €. It has an SJR impact factor of 0,476 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,476.
Anti-Cancer Drugs focuses its scope in these topics and keywords: antitumor, modulator, carcinoma, prognostic, efficacy, effects, gastrointestinal, glasgow, hepatocellular, enhances, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
2040 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,476
SJR Impact factor102
H Index143
Total Docs (Last Year)526
Total Docs (3 years)4507
Total Refs1045
Total Cites (3 years)525
Citable Docs (3 years)1.89
Cites/Doc (2 years)31.52
Ref/DocOther journals with similar parameters
Journal of Toxicology Q3
Journal of Antibiotics Q3
Human Psychopharmacology Q3
Current molecular pharmacology Q3
Journal of Physiology and Pharmacology Q3
Compare this journals
Aims and Scope
Best articles by citations
Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells
View moreAssessment of cyclooxygense-2 expression with 99mTc-labeled celebrex
View more19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil
View moreEfficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 status
View moreCongestive heart failure in a 77-year-old woman receiving adjuvant treatment with imatinib for a large gastric gastrointestinal stromal tumour
View moreIn-vitro cell tests using doxorubicin-loaded polymeric TiO2 nanotubes used for cancer photothermotherapy
View moreApoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer
View morePI3K-d inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells
View moreZerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity
View moreReversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells
View moreMultidrug resistance
View moreCaffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the ??-catenin/T-cell factor signaling
View moreObservation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer
View moreThe importance of DT-diaphorase and hypoxia in the cytotoxicity of RH1 in human breast and non-small cell lung cancer cell lines
View moreEmerging antibody-targeted therapy in leukemia and lymphoma: current concepts and clinical implications
View moreOvercoming the resistance to BRAF inhibitor by the double BRAF and MEK inhibitions in advanced melanoma
View moreTumour flare reaction in cancer treatments
View moreGosha-jinki-gan reduced oxaliplatin-induced hypersensitivity to cold sensation and its effect would be related to suppression of the expression of TRPM8 and TRPA1 in rats
View moreApproach to a multiparametric sensor-chip-based tumor chemosensitivity assay
View moreThe new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells
View moreL-Methionine inhibits growth of human pancreatic cancer cells
View moreAntimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study
View moreNPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent
View moreReversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives
View more
Comments